331 related articles for article (PubMed ID: 33262224)
41. Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs).
Li Q; Guo D; Dong Z; Zhang W; Zhang L; Huang SM; Polli JE; Shu Y
Toxicol Appl Pharmacol; 2013 Nov; 273(1):100-9. PubMed ID: 24001450
[TBL] [Abstract][Full Text] [Related]
42. Multidrug and toxin extrusion proteins mediate cellular transport of cadmium.
Yang H; Guo D; Obianom ON; Su T; Polli JE; Shu Y
Toxicol Appl Pharmacol; 2017 Jan; 314():55-62. PubMed ID: 27871888
[TBL] [Abstract][Full Text] [Related]
43. No Inhibition of MATE1/2K-Mediated Renal Creatinine Secretion Predicted With Ritonavir or Cobicistat.
Kikuchi R; Chiou WJ; Kasai MA; de Morais SM; Bow DAJ
J Pharm Sci; 2019 Sep; 108(9):3118-3123. PubMed ID: 31034908
[TBL] [Abstract][Full Text] [Related]
44. Synchronized activity of organic cation transporter 3 (Oct3/Slc22a3) and multidrug and toxin extrusion 1 (Mate1/Slc47a1) transporter in transplacental passage of MPP+ in rat.
Ahmadimoghaddam D; Hofman J; Zemankova L; Nachtigal P; Dolezelova E; Cerveny L; Ceckova M; Micuda S; Staud F
Toxicol Sci; 2012 Aug; 128(2):471-81. PubMed ID: 22543277
[TBL] [Abstract][Full Text] [Related]
45. N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction.
Müller F; Pontones CA; Renner B; Mieth M; Hoier E; Auge D; Maas R; Zolk O; Fromm MF
Eur J Clin Pharmacol; 2015 Jan; 71(1):85-94. PubMed ID: 25552403
[TBL] [Abstract][Full Text] [Related]
46. The involvement of multidrug and toxin extrusion protein 1 in the distribution and excretion of berberine.
Xiao L; Xue Y; Zhang C; Wang L; Lin Y; Pan G
Xenobiotica; 2018 Mar; 48(3):314-323. PubMed ID: 28298174
[TBL] [Abstract][Full Text] [Related]
47. Cynomolgus Monkey as a Clinically Relevant Model to Study Transport Involving Renal Organic Cation Transporters: In Vitro and In Vivo Evaluation.
Shen H; Liu T; Jiang H; Titsch C; Taylor K; Kandoussi H; Qiu X; Chen C; Sukrutharaj S; Kuit K; Mintier G; Krishnamurthy P; Fancher RM; Zeng J; Rodrigues AD; Marathe P; Lai Y
Drug Metab Dispos; 2016 Feb; 44(2):238-49. PubMed ID: 26608080
[TBL] [Abstract][Full Text] [Related]
48. Interactions of tyrosine kinase inhibitors with organic cation transporters and multidrug and toxic compound extrusion proteins.
Minematsu T; Giacomini KM
Mol Cancer Ther; 2011 Mar; 10(3):531-9. PubMed ID: 21252289
[TBL] [Abstract][Full Text] [Related]
49. Effect of Cimetidine on Metformin Pharmacokinetics and Endogenous Metabolite Levels in Rats.
Ailabouni AS; Mettu VS; Thakur A; Singh DK; Prasad B
Drug Metab Dispos; 2024 Jan; 52(2):86-94. PubMed ID: 38049999
[TBL] [Abstract][Full Text] [Related]
50. Molecular determinants of ligand selectivity for the human multidrug and toxin extruder proteins MATE1 and MATE2-K.
Astorga B; Ekins S; Morales M; Wright SH
J Pharmacol Exp Ther; 2012 Jun; 341(3):743-55. PubMed ID: 22419765
[TBL] [Abstract][Full Text] [Related]
51. Indinavir Alters the Pharmacokinetics of Lamivudine Partially via Inhibition of Multidrug and Toxin Extrusion Protein 1 (MATE1).
Li Q; Ye Z; Zhu P; Guo D; Yang H; Huang J; Zhang W; Polli JE; Shu Y
Pharm Res; 2018 Jan; 35(1):14. PubMed ID: 29302757
[TBL] [Abstract][Full Text] [Related]
52. Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2).
Zolk O; Solbach TF; König J; Fromm MF
Naunyn Schmiedebergs Arch Pharmacol; 2009 Apr; 379(4):337-48. PubMed ID: 19002438
[TBL] [Abstract][Full Text] [Related]
53. In vitro validation of an in vivo phenotyping drug cocktail for major drug transporters in humans.
Hsin CH; Kuehne A; Gu Y; Jedlitschky G; Hagos Y; Gründemann D; Fuhr U
Eur J Pharm Sci; 2023 Jul; 186():106459. PubMed ID: 37142000
[TBL] [Abstract][Full Text] [Related]
54. Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia.
Nishizawa K; Yoda N; Morokado F; Komori H; Nakanishi T; Tamai I
PLoS One; 2019; 14(4):e0214862. PubMed ID: 30951542
[TBL] [Abstract][Full Text] [Related]
55. Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms.
Meyer zu Schwabedissen HE; Verstuyft C; Kroemer HK; Becquemont L; Kim RB
Am J Physiol Renal Physiol; 2010 Apr; 298(4):F997-F1005. PubMed ID: 20053795
[TBL] [Abstract][Full Text] [Related]
56. Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Wittwer MB; Zur AA; Khuri N; Kido Y; Kosaka A; Zhang X; Morrissey KM; Sali A; Huang Y; Giacomini KM
J Med Chem; 2013 Feb; 56(3):781-795. PubMed ID: 23241029
[TBL] [Abstract][Full Text] [Related]
57. Relationship of MATE1 Inhibition and Cytotoxicity in Nephrotoxicity: Application for Safety Evaluation in Early Drug Discovery.
Tohyama K; Chisaki I; Takai Y; Handa Y; Miyamoto M; Amano N
Toxicol Sci; 2019 Jul; 170(1):223-233. PubMed ID: 31020312
[TBL] [Abstract][Full Text] [Related]
58. Potent and specific inhibition of mMate1-mediated efflux of type I organic cations in the liver and kidney by pyrimethamine.
Ito S; Kusuhara H; Kuroiwa Y; Wu C; Moriyama Y; Inoue K; Kondo T; Yuasa H; Nakayama H; Horita S; Sugiyama Y
J Pharmacol Exp Ther; 2010 Apr; 333(1):341-50. PubMed ID: 20065018
[TBL] [Abstract][Full Text] [Related]
59. Renal tubular secretion of pramipexole.
Knop J; Hoier E; Ebner T; Fromm MF; Müller F
Eur J Pharm Sci; 2015 Nov; 79():73-8. PubMed ID: 26360835
[TBL] [Abstract][Full Text] [Related]
60. Molecular identification and functional characterization of rabbit MATE1 and MATE2-K.
Zhang X; Cherrington NJ; Wright SH
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F360-70. PubMed ID: 17442726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
